Previous Article | Next Article ![]()
Journal of Clinical Microbiology, May 2006, p. 1884-1886, Vol. 44, No. 5
0095-1137/06/$08.00+0 doi:10.1128/JCM.44.5.1884-1886.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Departments of Gastrointestinal Sciences,1 Community Health, Christian Medical College, Vellore, India2
Received 29 November 2005/ Returned for modification 26 January 2006/ Accepted 7 March 2006
|
|
|---|
|
|
|---|
Consecutive patients with intestinal tuberculosis seen in the Department of Gastrointestinal Sciences between April 2003 and January 2005 were included. The diagnosis was made on the basis of one of the following criteria: (i) intestinal biopsies showing caseating granulomas, (ii) intestinal granulomas accompanied by confirmed extraintestinal tuberculosis, (iii) endoscopic findings of TB with noncaseating granulomas on biopsy and complete resolution after antituberculosis therapy, or (iv) culture of M. tuberculosis from intestinal biopsy specimens. All patients were negative for acid-fast bacilli in induced-sputum specimens. Twenty-four subjects with irritable bowel syndrome (all with normal hematology and colonoscopy) undergoing colonoscopy during this period and six healthy adult volunteers served as controls. Fourteen patients with pulmonary TB and acid-fast bacilli on Ziehl-Neelsen stain of sputum smears were recruited from the DOTS Clinic of Christian Medical College, Vellore, India. Eight patients with intestinal tuberculosis who completed 9 months of antituberculosis therapy and were clinically symptom free with normal hemoglobin, sedimentation rate, serum albumin, and globulin were included. The protocol and consent forms were approved by the Research Committee of the Christian Medical College, Vellore, India.
Fresh feces were collected after consent and stored at 20°C. Feces (250 mg) were homogenized in 2 ml sterile phosphate-buffered saline and heated at 90°C for 15 min. After centrifugation (500 x g, 3 min), the supernatant was mixed with lysozyme (10 mg/ml) (Genei, India) and incubated at 37°C for 1 h; then, proteinase K (Genei, India) (30 mg/ml) and 20% sodium dodecyl sulfate (Sigma, India) were added, and the mixture was incubated at 55°C for 2 h. Following centrifugation (9,000 x g, 10 min) nucleic acid was extracted from the supernatant by using equal volumes of equilibrated phenol (pH 8.0; Ambion) and chloroform-isoamyl alcohol (25:24:1). DNA was precipitated with ethanol and 2.5 M ammonium acetate (2.0:0.1, 20°C, 1 h), pelleted (18,000 x g, 20 min), washed with 70% ethanol, air dried, resuspended in 50 µl sterile water, and stored at 20°C (12). A positive control was prepared from killed culture of Mycobacterium tuberculosis strain H37Rv. The primers used (MTB1, 5' CCT GCG AGC GTA GGC GTC GG 3', and MTB2, 5' CTC GTC CAG CGC CGC TTC GG 3') amplified a 123-bp fragment of IS6110 (5), which is specific for M. tuberculosis and contains an internal endonuclease site that allows confirmation of the product by digestion with SalI. PCR amplification in 10 µl used titanium Taq polymerase (BD Biosciences Clontech) and 10 pmol of each primer (Sigma, Bangalore, India). The final PCR conditions consisted of an initial denaturation at 95°C for 30 s, followed by 40 cycles of denaturation (94°C, 30 s), annealing (68°C, 30 s), and extension (72°C, 30 s), with a final extension for 10 min. The PCR product was subjected to electrophoresis on 2% agarose, stained with ethidium bromide, and imaged (Bio-Rad). The PCR products were digested with 10 U/µl of SalI (MBI Fermentas) at 37°C overnight, followed by electrophoresis on 3% agarose. Specificity of the primers was tested by sequence searches against prokaryotic DNA databases, in silico PCRs, and PCR using DNA from atypical mycobacteriaM. avium, M. kansasii, and M. fortuitum. Serial 10-fold dilutions of M. tuberculosis H37Rv (3) were added to PCR-negative fecal samples to establish the detection limit of PCR. All samples that tested positive were reconfirmed using two additional DNA extracts.
PCR using M. tuberculosis H37Rv, but not atypical mycobacteria, produced a 123-bp amplicon (Fig. 1, top left). With serial dilutions, PCR was able to detect >10 copies of M. tuberculosis. SalI digestion of the PCR product from positive cases and the positive control produced two bands, one of 66 bp and one of 57 bp, respectively (Fig. 1, bottom left). The specific PCR product was noted for 16 of 18 patients with untreated intestinal tuberculosis (Fig. 1, top right). Samples were negative by PCR for all 30 control subjects (Fig. 1, top left) and all eight treated gastrointestinal TB patients, five of whom were tested prior to therapy and were positive and three of whom were not tested prior to therapy. Twelve of 14 patients with smear-positive pulmonary tuberculosis tested positive (Fig. 1, bottom right), indicating fecal excretion of swallowed organisms. The sensitivity of fecal PCR for the diagnosis of intestinal TB was 88.8%, and the specificity was 100% (Table 1). In comparison to results with fecal PCR, 9/18 and 6/18 patients with intestinal TB tested positive by histopathology and culture, indicating sensitivities of 50% and 33.3%, respectively.
![]() View larger version (32K): [in a new window] |
FIG. 1. Electrophoresis of PCR products on a 2% agarose gel (top panels and bottom right panel) or PCR product digest on a 3% agarose gel (bottom left panel). In each panel, lane M is the molecular weight marker. (Top left) Lanes 1 to 11 are DNA isolated from feces of control subjects. Lane 12 shows amplification of a 123-bp fragment from the positive-control DNA. (Bottom left) Digested PCR products, showing 66- and 57-bp fragments. Lanes 1 to 6, results from intestinal TB patients; lanes 7 and 8, results from pulmonary TB patients. Lane 9 is the positive control. (Top right) Lanes 1 to 11 show results from various intestinal TB patients, while lane 12 is a positive control. (Bottom right) Lanes 1 to 11 show results from patients with smear-positive pulmonary TB, while lane 12 shows the positive control.
|
|
View this table: [in a new window] |
TABLE 1. Outcome of fecal PCR for IS6110 of M. tuberculosis in the various groups studied
|
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»